References
- Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. Am J Clin Dermatol. 2002;3:141–147.
- Munro DD. The effect of percutaneously absorbed steroids on hypothalamic–pituitary–adrenal function after intensive use in in-patients. Br J Dermatol. 1976;94(suppl 12):67–76.
- Gip L, Hamfelt A. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses. Cutis. 1984;33:215–222.
- Weston WL, Fennessey PV, Morelli J, Schwab H, Mooney J, Samson C, Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol. 1988;90:532–535.
- Hehir M, Du VA, Eilon L, Danie MJ, Shenoy EV. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment. Clin Exp Dermatol. 1983;8:143–151.
- Antignac JP, Brosseaud A, Gaudin-Hirret I, André F, Bizec BL. Analytical strategies for the direct mass spectrometric analysis of steroid and corticosteroid phase II metabolites. Steroids. 2005;70:205–216.
- Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh). 1980;92(suppl):44–47.
- Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157:645–648.
- Sparidans RW, van Velsen SG, de Roos MP, Schellens JH, Bruijnzeel-Koomen CA, Beijnen JH. Liquid chromatography-tandem mass spectrometric assay or clobetasol propionate in human serum from patients with atopic dermatitis. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2150–2154.
- Farmacotherapeutisch Kompas 2009, The Netherlands [accessed December 2009]. Available from: http://www.farmacotherapeutischkompas.nl.
- Wilson L, Williams DI, Marsh S. Plasma corticosteroid levels in out-patients treated with topical steroids. Br J Dermatol. 1973;88:373–380.
- Carruthers JA, August PJ, Staughton RC. Observations on the systemic effect of topical clobetasol propionate (Dermovate). Br Med J. 1975;4:203–204.
- Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–1494.
- Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25:559–566.
- Watson AC, Rosenfield RL, Fang VS. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin Endocrinol (Oxf). 1988;28:471–477.
- Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2008;8:1.
- Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346:321–327.